Health-care companies fell, giving back some recent gains related to a compromise between the U.S. and one major drug maker.
Shares of Pfizer, which has agreed to sell Americans pharmaceuticals at a discount through a proposed TrumpRx website, fell by more than 3%.
Shares of health insurer Humana added to their recent gains.
Biotech firm Amgen slashed the price of its cholesterol medication by more than half for U.S. patients through a new medication-access program amid the Trump administration's call to lower drug prices.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.